Mattias Eiber

10PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapyAnimal growth and development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 29, 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study.

|Apr 28, 2026
177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Dec 09, 2025
Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET.

Sungmin Woo, Benedetta Masci, Steven P Rowe

|Nov 15, 2025
The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.

Frederik L Giesel, Stefan A Koerber, Boris Hadaschik

|Feb 25, 2025
Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after 177Lu Prostate-specific Membrane Antigen-I&T Radioligand Therapy.

Lisa Steinhelfer, Friederike Jungmann, Manuel Nickel

|Jul 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.

Andrei Gafita, Loïc Djaileb, Isabel Rauscher

Pageof 2

Frequent Collaborators

3 joint publications

Ken Herrmann

3 joint publications

Jérémie Calais

3 joint publications

Isabel Rauscher

2 joint publications

Hebert Alberto Vargas